Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases

<p>Abstract</p> <p>Background</p> <p>Prostate Cancer (PCa) is the second most frequent neoplasia in men worldwide. Previous reports suggest that the prevalence of PCa in Hispanic males is lower than in Africans (including communities with African ancestry) and Caucasian...

Full description

Bibliographic Details
Main Authors: Garza-Guajardo Raquel, Morales-Rodriguez Idelma B, Martinez-Villarreal Rebeca T, Ortiz-Lopez Rocio, Alcantara-Aragon Valeria, Martinez-Fierro Margarita L, Gomez-Guerra Lauro S, Ponce-Camacho Marco A, Rojas-Martinez Augusto
Format: Article
Language:English
Published: BMC 2009-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/91
id doaj-d674634d51c1449ebc518dd08fa8cd20
record_format Article
spelling doaj-d674634d51c1449ebc518dd08fa8cd202020-11-25T02:35:00ZengBMCBMC Cancer1471-24072009-03-01919110.1186/1471-2407-9-91Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected casesGarza-Guajardo RaquelMorales-Rodriguez Idelma BMartinez-Villarreal Rebeca TOrtiz-Lopez RocioAlcantara-Aragon ValeriaMartinez-Fierro Margarita LGomez-Guerra Lauro SPonce-Camacho Marco ARojas-Martinez Augusto<p>Abstract</p> <p>Background</p> <p>Prostate Cancer (PCa) is the second most frequent neoplasia in men worldwide. Previous reports suggest that the prevalence of PCa in Hispanic males is lower than in Africans (including communities with African ancestry) and Caucasians, but higher than in Asians. Despite these antecedents, there are few reports of open population screenings for PCa in Latin American communities. This article describes the results of three consecutive screenings in the urban population of Monterrey, Mexico.</p> <p>Methods</p> <p>After receiving approval from our University Hospital's Internal Review Board (IRB), the screening was announced by radio, television, and press, and it was addressed to male subjects over 40 years old in general. Subjects who consented to participate were evaluated at the primary care clinics of the University Health Program at UANL, in the Metropolitan area of Monterrey. Blood samples were taken from each subject for prostate specific antigen (PSA) determination; they underwent a digital rectal examination (DRE), and were subsequently interviewed to obtain demographic and urologic data. Based on the PSA (>4.0 ng/ml) and DRE results, subjects were appointed for transrectal biopsy (TRB).</p> <p>Results</p> <p>A total of 973 subjects were screened. Prostate biopsy was recommended to 125 men based on PSA values and DRE results, but it was performed in only 55 of them. 15 of these biopsied men were diagnosed with PCa, mostly with Gleason scores ≥ 7.</p> <p>Conclusion</p> <p>Our results reflect a low prevalence of PCa in general, but a high occurrence of high grade lesions (Gleason ≥ 7) among patients that resulted positive for PCa. This observation remarks the importance of the PCa screening programs in our Mexican community and the need for strict follow-up campaigns.</p> http://www.biomedcentral.com/1471-2407/9/91
collection DOAJ
language English
format Article
sources DOAJ
author Garza-Guajardo Raquel
Morales-Rodriguez Idelma B
Martinez-Villarreal Rebeca T
Ortiz-Lopez Rocio
Alcantara-Aragon Valeria
Martinez-Fierro Margarita L
Gomez-Guerra Lauro S
Ponce-Camacho Marco A
Rojas-Martinez Augusto
spellingShingle Garza-Guajardo Raquel
Morales-Rodriguez Idelma B
Martinez-Villarreal Rebeca T
Ortiz-Lopez Rocio
Alcantara-Aragon Valeria
Martinez-Fierro Margarita L
Gomez-Guerra Lauro S
Ponce-Camacho Marco A
Rojas-Martinez Augusto
Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
BMC Cancer
author_facet Garza-Guajardo Raquel
Morales-Rodriguez Idelma B
Martinez-Villarreal Rebeca T
Ortiz-Lopez Rocio
Alcantara-Aragon Valeria
Martinez-Fierro Margarita L
Gomez-Guerra Lauro S
Ponce-Camacho Marco A
Rojas-Martinez Augusto
author_sort Garza-Guajardo Raquel
title Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
title_short Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
title_full Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
title_fullStr Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
title_full_unstemmed Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases
title_sort population based prostate cancer screening in north mexico reveals a high prevalence of aggressive tumors in detected cases
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2009-03-01
description <p>Abstract</p> <p>Background</p> <p>Prostate Cancer (PCa) is the second most frequent neoplasia in men worldwide. Previous reports suggest that the prevalence of PCa in Hispanic males is lower than in Africans (including communities with African ancestry) and Caucasians, but higher than in Asians. Despite these antecedents, there are few reports of open population screenings for PCa in Latin American communities. This article describes the results of three consecutive screenings in the urban population of Monterrey, Mexico.</p> <p>Methods</p> <p>After receiving approval from our University Hospital's Internal Review Board (IRB), the screening was announced by radio, television, and press, and it was addressed to male subjects over 40 years old in general. Subjects who consented to participate were evaluated at the primary care clinics of the University Health Program at UANL, in the Metropolitan area of Monterrey. Blood samples were taken from each subject for prostate specific antigen (PSA) determination; they underwent a digital rectal examination (DRE), and were subsequently interviewed to obtain demographic and urologic data. Based on the PSA (>4.0 ng/ml) and DRE results, subjects were appointed for transrectal biopsy (TRB).</p> <p>Results</p> <p>A total of 973 subjects were screened. Prostate biopsy was recommended to 125 men based on PSA values and DRE results, but it was performed in only 55 of them. 15 of these biopsied men were diagnosed with PCa, mostly with Gleason scores ≥ 7.</p> <p>Conclusion</p> <p>Our results reflect a low prevalence of PCa in general, but a high occurrence of high grade lesions (Gleason ≥ 7) among patients that resulted positive for PCa. This observation remarks the importance of the PCa screening programs in our Mexican community and the need for strict follow-up campaigns.</p>
url http://www.biomedcentral.com/1471-2407/9/91
work_keys_str_mv AT garzaguajardoraquel populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT moralesrodriguezidelmab populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT martinezvillarrealrebecat populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT ortizlopezrocio populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT alcantaraaragonvaleria populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT martinezfierromargarital populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT gomezguerralauros populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT poncecamachomarcoa populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
AT rojasmartinezaugusto populationbasedprostatecancerscreeninginnorthmexicorevealsahighprevalenceofaggressivetumorsindetectedcases
_version_ 1724805890901540864